Business model
Genome-editing
About us
Contact us here
2020.05.25 Alliance
C4U and Noile-Immune Biotech Partnership on PRIME Allogeneic CAR-T Cell Therapy Using CRISPR/Cas3 Genome Editing Technology
2019.12.06 R&D
The paper was published in nature communications.
